TMCI SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 8, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 27, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Treace Medical Concepts Reports Third Quarter 2026 Financial Results and Updates Full-Year Guidance

Nov 6, 2026

8-K

Treace Medical Concepts Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Aug 7, 2026

8-K

Treace Medical Concepts, Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 20, 2026

8-K

Treace Medical Concepts Reports First Quarter 2026 Financial Results

May 8, 2026

8-K

Treace Medical Concepts Announces Executive Departure and Preliminary Q1 2026 Financial Results

Apr 9, 2026

8-K

Treace Medical Concepts Reports Q4 and Full-Year 2025 Financial Results, Issuing 2026 Revenue Guidance

Feb 27, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

SHELF OFFERING | Shares amount: 4,761,905 | Share price: $21.00 | Offering amount: $100,000,005.00 | Bank: J.P. Morgan, Morgan Stanley, Stifel, Truist Securities, BTIG

Feb 8, 2023

424B5

.00 | Offering amount: $100,000,000.00 | Bank: J.P. Morgan, Morgan Stanley, Stifel, Truist Securities, BTIG

Feb 7, 2023

424B4

11,250,000 Shares-

Apr 26, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8